scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.IJCARD.2005.10.016 |
P8608 | Fatcat ID | release_ocnrb44oorcjda7tqyq6zkkqwe |
P698 | PubMed publication ID | 16316696 |
P2093 | author name string | Junbo Ge | |
Chun Liang | |||
Chengxing Shen | |||
Juying Qian | |||
Lianglong Chen | |||
Haozhu Chen | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 85-90 | |
P577 | publication date | 2005-11-28 | |
P1433 | published in | International Journal of Cardiology | Q2357863 |
P1476 | title | Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. | |
P478 | volume | 112 |
Q33755946 | A novel mouse model of in-stent restenosis |
Q84963515 | Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation |
Q36584877 | Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with |
Q42931550 | Effect of oral sirolimus therapy on inflammatory biomarkers following coronary stenting |
Q37588002 | Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era. |
Q42465609 | Human lung parenchyma but not proximal bronchi produces fibroblasts with enhanced TGF-beta signaling and alpha-SMA expression. |
Q51722550 | In vivo monitoring of the inflammatory response in a stented mouse aorta model. |
Q38014069 | Matrix metalloproteinases |
Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
Q46817750 | Plasminogen activator inhibitor-1 predicts coronary in-stent restenosis of drug-eluting stents. |
Q37930965 | Restenosis after PCI. Part 1: pathophysiology and risk factors |
Q51153261 | Sudden cardiac death: An 11-year postmortem analysis in the region of Epirus, Greece |
Q47592395 | The application of multiscale modelling to the process of development and prevention of stenosis in a stented coronary artery |
Q49984918 | Vitronectin and Urokinase-Type Plasminogen Activator Gene Expression Levels Are Increased in Patients with Coronary Artery In-Stent Restenosis |
Search more.